Next Article in Journal
Bioactive Isopimarane Diterpenes from the Fungus, Epicoccum sp. HS-1, Associated with Apostichopus japonicus
Previous Article in Journal
Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2015, 13(3), 1105-1123; doi:10.3390/md13031105

Anticancer Properties of Lamellarins

Pierre Fabre Research Institute, Research & Development Center, 3 Avenue Hubert Curien, BP 13562, 31035 Toulouse cedex 1, France
Academic Editor: David J. Newman
Received: 28 October 2014 / Revised: 24 December 2014 / Accepted: 13 February 2015 / Published: 19 February 2015
View Full-Text   |   Download PDF [874 KB, uploaded 24 February 2015]   |  

Abstract

In 1985 the first lamellarins were isolated from a small oceanic sea snail. Today, more than 50 lamellarins have been inventoried and numerous derivatives synthesized and tested as antiviral or anticancer agents. The lead compound in the family is lamellarin D, characterized as a potent inhibitor of both nuclear and mitochondrial topoisomerase I but also capable of directly interfering with mitochondria to trigger cancer cell death. The pharmacology and chemistry of lamellarins are discussed here and the mechanistic portrait of lamellarin D is detailed. Lamellarins frequently serve as a starting point in the design of anticancer compounds. Extensive efforts have been devoted to create novel structures as well as to improve synthetic methods, leading to lamellarins and related pyrrole-derived marine alkaloids. View Full-Text
Keywords: lamellarins; marine natural products; cancer; topoisomerase I; mitochondria; drug synthesis lamellarins; marine natural products; cancer; topoisomerase I; mitochondria; drug synthesis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bailly, C. Anticancer Properties of Lamellarins. Mar. Drugs 2015, 13, 1105-1123.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top